After Brian exhausted all treatment options in the United States, he pursued an innovative therapy for his stage IV prostate cancer in Israel. Click here to discover his story:

Having lost her mother and grandmother to breast cancer, Anna was determined not to share their fate. To learn more about Anna's battle with cancer, click here:

New studies indicate the high efficacy of novel immunotherapies, now available at Sheba, for patients with relapsed or refractory hematological malignancies.

Sheba researchers developed a revolutionary cancer treatment involving the reprogramming of the immune system of terminally ill patients to attack cancerous cells utilizing a gut microbiome transplant. Learn more.

Recent research conducted in Israel showed how the CRISPR-Cas9 gene editing system can be effective against metastatic cancer.

The 6th World Congress on Controversies in Multiple Myeloma (COMy) was held virtually during the first week of October 2020.

Testing of Canady Helios™ Cold Plasma demonstrated exciting results as an effective breast cancer treatment across many different cell lines.

Study explores the benefits of treating patients with CAR-T cell therapeutics manufactured on-site, as opposed to using commercially manufactured products.

Colon cancer begins in the large intestine, in the final part of the digestive tract. Starting as small, benign polyps on the inside of the colon, this disease most commonly affects older adults.